Tracked funds were net sellers of Johnson & Johnson (JNJ) in 2026 Q1, 8 to 2, across the filings received from the 94 tracked funds for the quarter so far. Of the buyers, 2 added to an existing position. Of the sellers, 8 trimmed.
Who moved on JNJ in 2026 Q1?
Across the filings received from the 94 tracked funds for 2026 Q1 at the time of writing.
| Value | |
|---|---|
| Buyers | 2 (0 opened, 2 added) |
| Sellers | 8 (0 sold out, 8 trimmed) |
| Net | 6 more sellers than buyers |
| Holders among the filers | 12 |
| Funds filed so far | 94 |
Which funds bought and sold JNJ?
The largest buyers of JNJ in 2026 Q1 were Paul Lountzis and Thomas Russo. The largest sellers were Donald Yacktman, Independent Franchise Partners and Mairs & Power Growth Fund.
Who held JNJ after the 2026 Q1 filings?
Among the 94 tracked funds that had filed for 2026 Q1, 12 hold JNJ. The largest positions by portfolio weight were Charles Bobrinskoy (5.41%), Tweedy, Browne Co All Funds (US) (4.26%) and Donald Yacktman (4.07%). Every tracked holder of JNJ is on the JNJ ownership page.
FAQ
How many tracked funds bought JNJ in 2026 Q1?
2 tracked funds bought JNJ in 2026 Q1: none opened a position and 2 added to one.
Which funds sold JNJ in 2026 Q1?
8 tracked funds sold JNJ: none sold out and 8 trimmed. The largest sellers were Donald Yacktman, Independent Franchise Partners and Mairs & Power Growth Fund.
How many tracked funds hold JNJ?
Among the 94 tracked funds that had filed for 2026 Q1, 12 hold JNJ.
Can these counts still change?
Yes. The counts cover the 94 tracked funds that had filed for 2026 Q1 when this was written; funds that file later are not included.